Search results
Results from the WOW.Com Content Network
Delsam Pharma Artificial Tears Lubricant Eye Drops: Also linked to current bacterial infections, this product is also manufactured by Global Pharma Healthcare. Recalled products can be identified ...
The agency recommended against the usage of 26 over-the-counter eye drop products mainly used to treat symptoms of dry eyes and provide relief against eye irritation.
The FDA is advising consumers not to use these 27 eye drop products after uncovering unsanitary conditions at a manufacturing facility.
ST8:USA300 is a strain of community-associated methicillin-resistant Staphylococcus aureus that has emerged as a particularly antibiotic resistant epidemic that is responsible for rapidly progressive, fatal diseases including necrotizing pneumonia, severe sepsis and necrotizing fasciitis. [1]
MRSA blood infections in Latin America was 29%. European incidence was 22.8%. The rate of all MRSA infections in Europe ranged from 50% in Portugal down to 0.8% in Sweden. Overall MRSA infection rates varied in Latin America: Colombia and Venezuela combined had 3%, Mexico had 50%, Chile 38%, Brazil 29%, and Argentina 28%. [89]
The 2022–2023 United States Pseudomonas aeruginosa outbreak began in May 2022, with the infection of several patients in California. The Centers for Disease Control and Prevention (CDC) became aware of a strain of Pseudomonas aeruginosa in artificial tears manufactured by EzriCare and Delsam Pharma in January 2023.
Infections usually occur in hospital settings among people with weakened immune systems. As many as 37 patients were linked to four health care facility outbreaks, the CDC reported.
Los Angeles County has reported four cases of an extensively drug-resistant bacterial infection that has caused blindness, hospitalization and one death nationwide.